Financhill
Back

ProShares Ultra Health Care Quote, Financials, Valuation and Earnings

U.S. Government Report Alert Tuesday

Discover the Secret Loophole
Sell
32

RXL
ProShares Ultra Health Care

Last Price:
100.00
Seasonality Move:
8.19%

7 Day Trial

ALL ACCESS PASS

$ 7

The Mysterious VC Firm Behind Nvidia's Secret Weapon

Details Here!

ProShares Ultra Health Care Price Quote

$100.00
-0.78 (-0.77%)
(Updated: November 5, 2024 at 4:05 PM ET)

ProShares Ultra Health Care Key Stats

Sell
32
ProShares Ultra Health Care (RXL) is a Sell

Day range:
$100.78 - $102.56
52-week range:
$76.97 - $117.47
Dividend yield:
0.94%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
0%

Volume:
3.1K
Avg. volume:
2.2K
1-year change:
25.44%
Market cap:
$0
Revenue:
$0
EPS:
$0

How Much Does ProShares Ultra Health Care Make?

Data Unavailable

Is ProShares Ultra Health Care Growing As A Company?

Data Unavailable

ProShares Ultra Health Care Stock Price Performance

What Is ProShares Ultra Health Care 52-Week High & Low?

ProShares Ultra Health Care Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy ProShares Ultra Health Care?

Data Unavailable

Is ProShares Ultra Health Care Cash Flow Positive?

Data Unavailable

ProShares Ultra Health Care Return On Invested Capital

Data Unavailable

ProShares Ultra Health Care Earnings Date & Stock Price

ProShares Ultra Health Care Competitors

  • Who Are ProShares Ultra Health Care's Competitors?
    Below is a list of companies who compete with ProShares Ultra Health Care or are related in some way:
    • Direxion Daily Healthcare Bull 3X ETF (CURE)
    • ProShares Ultra Dow30 (DDM)
    • Direxion Daily South Korea Bull 3X ETF (KORU)
    • MicroSectorsTM Oil&Gs Exp&Pd 3X Lvg ETNs (OILU)
    • ProShares Ultra Consumer Staples (UGE)

ProShares Ultra Health Care Dividend Yield

ProShares Ultra Health Care Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 0.00
Downside from Last Price: -100%

Major Shareholders

Data Unavailable